interventions and recently nci supported researchers developing two new interventions against pediatric leukemia and lymphoma and this was initially developed in the academic sector and has been picked up by venture capital and is vapdly going forward for clinical trials. and we also have interacting with the pharmaceutical industry to try to identify new and important uses for drugs that are off the shelf, either because they have been approved for one intervention but not for another, for example, braf inhibitors in melanoma, trying them in other diseases. this is a potentially very important innovation because we recognize that a percentage of patients who have different kinds of cancers may actually have the same molecular abnormalities and therefore may benefit from targeted treatments initially developed in other areas. i could go on, but i think that given the time -- >> yeah. can you just tell me why immunotherapy is effective in some patients but not in others who have the same cancer? >> yes. i think that this is a critically important issue and i think that what we are doing to suppor

research nci supported developing 2 interventions against pediatric leukemia and lymphoma. this was initially developed in the academic sector and has been picked up by venture capital and is rapidly going forward for clinical trials. interacting with the pharmaceutical industry to try to identify new and important uses for drugs that are havehe-shelf because they been approved for one intervention but not for another. inhibitors and melanoma, trying them and other diseases. this is potentially a very important innovation because we recognize that a percentage of patients who have different kinds of cancers may have the same molecular abnormality and therefore may benefit from targeted treatments initially developed in other areas. i could go on but i think given the time -- me whyyou tell immunotherapy is effective in some patients but not in others who have the same cancer? >> yes, i think this is a critically important issue. doing to support research to understand mechanisms are critically important because if we could understand why some patients are benefiting whereas

leukemia and sickle cell anemia. >> but what surprises many parents is that now they are being researched to treat many more conditions like acquired hearing loss, autism, pediatric stroke and cerebral palsy. >> nothing was wrong during my pregnancy. it was just an insurance policy so we decided randomly to bank our court but. -- cord blood. when he was a tall it -- toddler he struggled to hit development of milestones. >> once we got the diagnosis of cerebral palsy we were shocked. >> reporter: they were ready to try anything to help them learn to walk and talk. they flew to southern california for an infusion with his own cord blood stem cells. the doctor gave him no guarantees. >> she was very hesitant to say it is not going -- it is going to work. she said it won't hurt him but i can't promise you anything. >> and we saw amazing results. >> good job honey! >> within a couple weeks he was using words and laughing. he did learn to walk and is currently a fourth grader who swims and does karate. >> to this day researchers alike, we don't know. >> we were just to parents trying to do the best for our kids and we are not scientists are doctors. it is really up to